ArticleBMC medicine2026

Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes: a population-based cohort study.

Minyoung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.